10 Best Growth Stocks Under $30 to Buy Now

8. CytomX Therapeutics Inc. (NASDAQ:CTMX)

Number of Hedge Fund Holders: 42

CytomX Therapeutics Inc. (NASDAQ:CTMX) is one of the best growth stocks under $30 to buy now. On June 3, CytomX expanded its research collaboration with Regeneron to develop next-gen conditionally-activated bispecific cancer therapies. By combining CytomX’s PROBODY masking platform with Regeneron’s Veloci-Bi technology, the partnership aims to create treatments that remain inactive until reaching the tumor microenvironment, potentially widening the therapeutic window and minimizing off-target effects.

Under the expanded agreement, CytomX will receive a $37 million target selection payment for two new programs. Furthermore, Regeneron has secured an option for six additional targets, bringing the total potential value of the collaboration, including research, development, regulatory, and sales-based milestones, to ~$4 billion, in addition to tiered royalties on future product sales.

Regeneron will remain responsible for funding the subsequent preclinical, clinical, and commercialization activities. Both companies emphasized that this expansion builds on the success of their initial 2022 alliance, reinforcing a shared commitment to advancing precision immunotherapy for challenging tumor types.

CytomX Therapeutics Inc. (NASDAQ:CTMX) is a clinical-stage biopharmaceutical company developing “masked” antibody therapeutics, known as PROBODY platforms, designed to activate specifically within tumor microenvironments. This approach targets cancer while minimizing damage to healthy tissue, focusing on antibody-drug conjugates/ADCs and T-cell engagers to treat advanced cancers.